Mechanisms of Ibrutinib Resistance in Chronic Lymphocytic Leukemia

1 Views
administrator
administrator
07/14/23

The panelists, William G. Wierda, MD, PhD; Thomas J. Kipps, MD, PhD; Richard R. Furman, MD; Alessandra Ferrajoli, MD; and Shuo Ma, MD, PhD, analyze mechanisms of ibrutinib resistance in chronic lymphocytic leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next